|Bid||6.10 x 4000|
|Ask||6.13 x 1800|
|Day's Range||5.93 - 6.22|
|52 Week Range||3.75 - 16.19|
|Beta (3Y Monthly)||3.11|
|PE Ratio (TTM)||20.60|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The markets were flat today as the Fed started its two-day meeting. Cannabis ETFs reported mixed performance, and cannabis stocks traded mostly in the red.
The Zacks Analyst Blog Highlights: Anheuser-Busch, Tilray, Boston Beer, Constellation Brands and Aphria
Aurora Cannabis posted its fourth-quarter earnings after the market closed on Wednesday. The company posted revenues of 98.9 million Canadian dollars.
Cronos Group and Aphria are Jim Cramer's top picks in the cannabis sector. Aphria’s upbeat earnings results restored investors' faith in the sector.
Aurora Cannabis (ACB) stock has been rising before its fourth-quarter earnings on Thursday. The stock has risen 12.4% this month.
On September 6, Aurora Cannabis and Aphria were trading at a higher forward EV-to-sales multiple than their peers’ median value of 12.26.
As the cannabis industry grows, Martha Stewart recently announced the launch of CBD-infused products in a partnership with Canopy Growth (CGC).
HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.
CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive
Curaleaf (CURLF) (CURA) reported its second-quarter earnings on Tuesday. The company reported a net loss of $0.05 per share on revenues of $48.5 million.
Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.
New York’s Carolyn Maloney expressed optimism about the House approving the SAFE Banking Act. The bill would open banking access to the cannabis industry.